2,0
11 sep 2014
Huidige werknemer, meer dan 8 jaar
New York, NY
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Very diversified company. Good exposure to both Life Sciences and Industrial business. Benefits in general are good but the endless cost cutting is taking a toll.
Minpunten
Senior leadership's goals are clearly short term. Financial community seems to not notice the complete lack of a long term strategy. Benefits and resource cost cutting are being offset by excessive executive compensation.